CURE.DE vs. WELG.DE
CURE.DE (VanEck Genomics and Healthcare Innovators UCITS ETF A) and WELG.DE (Amundi S&P Global Health Care ESG UCITS ETF EUR Dist) are both Health & Biotech Equities funds - CURE.DE tracks the MVIS Global Future Healthcare ESG while WELG.DE tracks the S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care. Both are passively managed. Over the past 3 years, CURE.DE returned -2.48%/yr vs 2.22%/yr for WELG.DE. At a 0.49 correlation, their price movements are largely independent. CURE.DE charges 0.35%/yr vs 0.18%/yr for WELG.DE.
Performance
CURE.DE vs. WELG.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE.DE achieves a -5.10% return, which is significantly lower than WELG.DE's -3.60% return.
CURE.DE
- 1D
- 4.01%
- 1M
- 6.73%
- YTD
- -5.10%
- 6M
- -8.62%
- 1Y
- 6.04%
- 3Y*
- -2.48%
- 5Y*
- —
- 10Y*
- —
WELG.DE
- 1D
- 2.97%
- 1M
- 3.72%
- YTD
- -3.60%
- 6M
- -3.07%
- 1Y
- 7.16%
- 3Y*
- 2.22%
- 5Y*
- —
- 10Y*
- —
CURE.DE vs. WELG.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | -5.10% | 5.09% | 0.30% | -6.42% | -3.35% |
WELG.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Dist | -3.60% | 1.26% | 7.51% | 1.94% | 4.13% |
Correlation
The correlation between CURE.DE and WELG.DE is 0.60, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.60 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Oct 12, 2022 | 0.49 |
The correlation between CURE.DE and WELG.DE shifts across timeframes, from 0.49 (3 years) to 0.60 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE.DE vs. WELG.DE — Risk / Return Rank
CURE.DE
WELG.DE
CURE.DE vs. WELG.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) and Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CURE.DE | WELG.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.18 | ||
| Sortino ratioReturn per unit of downside risk | -0.26 | ||
| Omega ratioGain probability vs. loss probability | 1.06 | 1.09 | -0.03 |
| Calmar ratioReturn relative to maximum drawdown | 0.30 | 0.55 | -0.25 |
| Martin ratioReturn relative to average drawdown | 0.68 | 1.29 | -0.61 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CURE.DE | WELG.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.29 | 0.47 | -0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.14 | 0.22 | -0.36 |
Drawdowns
CURE.DE vs. WELG.DE - Drawdown Comparison
The maximum CURE.DE drawdown since its inception was -34.80%, which is greater than WELG.DE's maximum drawdown of -23.11%. Use the drawdown chart below to compare losses from any high point for CURE.DE and WELG.DE.
Loading charts...
Drawdown Indicators
| CURE.DE | WELG.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -34.80% | -23.11% | -11.69% |
Max Drawdown (1Y)Largest decline over 1 year | -19.07% | -12.38% | -6.69% |
Max Drawdown (3Y)Largest decline over 3 years | -29.32% | -23.11% | -6.21% |
Current DrawdownCurrent decline from peak | -15.66% | -12.09% | -3.57% |
Average DrawdownAverage peak-to-trough decline | -15.12% | -7.24% | -7.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.53% | 5.34% | +3.19% |
Volatility
CURE.DE vs. WELG.DE - Volatility Comparison
VanEck Genomics and Healthcare Innovators UCITS ETF A (CURE.DE) has a higher volatility of 5.73% compared to Amundi S&P Global Health Care ESG UCITS ETF EUR Dist (WELG.DE) at 5.31%. This indicates that CURE.DE's price experiences larger fluctuations and is considered to be riskier than WELG.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE.DE | WELG.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.73% | 5.31% | +0.42% |
Volatility (6M)Calculated over the trailing 6-month period | 15.20% | 10.25% | +4.95% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.97% | 14.54% | +5.43% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.74% | 13.49% | +7.25% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.74% | 13.49% | +7.25% |
CURE.DE vs. WELG.DE - Expense Ratio Comparison
CURE.DE has a 0.35% expense ratio, which is higher than WELG.DE's 0.18% expense ratio.
Dividends
CURE.DE vs. WELG.DE - Dividend Comparison
CURE.DE has not paid dividends to shareholders, while WELG.DE's dividend yield for the trailing twelve months is around 1.55%.
| Position | TTM | 2025 | 2024 | 2023 |
|---|---|---|---|---|
CURE.DE VanEck Genomics and Healthcare Innovators UCITS ETF A | 0.00% | 0.00% | 0.00% | 0.00% |
WELG.DE Amundi S&P Global Health Care ESG UCITS ETF EUR Dist | 1.55% | 1.36% | 0.92% | 0.17% |
Frequently Asked Questions
CURE.DE and WELG.DE have a correlation of 0.60, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, WELG.DE is cheaper at 0.18% per year. The better choice depends on whether you care most about return, fees, risk, or income.
WELG.DE is cheaper with a 0.18% expense ratio, compared with 0.35% for CURE.DE.
CURE.DE tracks MVIS Global Future Healthcare ESG, while WELG.DE tracks S&P Developed Ex-Korea LargeMidCap Sustainability Enhanced Health Care. They also come from different issuers: VanEck and Amundi. Their fees differ too: 0.35% for CURE.DE and 0.18% for WELG.DE.
Find the right allocation for CURE.DE and WELG.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer